| Disease | Target Count | P-value |
|---|---|---|
| glioblastoma multiforme | 347 | 4.0e-20 |
| juvenile dermatomyositis | 1189 | 2.7e-09 |
| posterior fossa group A ependymoma | 1511 | 1.6e-08 |
| lung cancer | 4473 | 1.3e-05 |
| pilocytic astrocytoma | 3086 | 1.8e-05 |
| tuberculosis and treatment for 6 months | 686 | 2.2e-04 |
| atypical teratoid/rhabdoid tumor | 1095 | 2.4e-04 |
| acute quadriplegic myopathy | 1157 | 6.4e-04 |
| pediatric high grade glioma | 2712 | 1.6e-03 |
| medulloblastoma, large-cell | 6234 | 2.4e-03 |
| osteosarcoma | 7933 | 4.7e-03 |
| subependymal giant cell astrocytoma | 2287 | 8.7e-03 |
| ovarian cancer | 8491 | 1.1e-02 |
| invasive ductal carcinoma | 2950 | 1.2e-02 |
| aldosterone-producing adenoma | 664 | 1.6e-02 |
| hereditary spastic paraplegia | 313 | 2.8e-02 |
| Disease | log2 FC | p |
|---|---|---|
| glioblastoma multiforme | 1.400 | 4.0e-20 |
| osteosarcoma | 1.410 | 4.7e-03 |
| posterior fossa group A ependymoma | 1.700 | 1.6e-08 |
| atypical teratoid/rhabdoid tumor | 1.800 | 2.4e-04 |
| medulloblastoma, large-cell | -1.100 | 2.4e-03 |
| hereditary spastic paraplegia | -1.042 | 2.8e-02 |
| juvenile dermatomyositis | 1.483 | 2.7e-09 |
| acute quadriplegic myopathy | 1.384 | 6.4e-04 |
| tuberculosis and treatment for 6 months | -2.600 | 2.2e-04 |
| lung cancer | 1.900 | 1.3e-05 |
| pediatric high grade glioma | 1.200 | 1.6e-03 |
| pilocytic astrocytoma | 1.600 | 1.8e-05 |
| aldosterone-producing adenoma | -1.343 | 1.6e-02 |
| subependymal giant cell astrocytoma | 2.108 | 8.7e-03 |
| invasive ductal carcinoma | 1.100 | 1.2e-02 |
| ovarian cancer | -1.100 | 1.1e-02 |
MVPPRRHRGAGRPGVLSSSPPFRLRSAKFSGIALEDLRRALKTRLQMVCVFVMNRMNSQNSGFTQRRRMA 1 - 70 LGIVILLLVDVIWVASSELTSYVFTQYNKPFFSTFAKTSMFVLYLLGFIIWKPWRQQCTRGLRGKHAAFF 71 - 140 ADAEGYFAACTTDTTMNSSLSEPLYVPVKFHDLPSEKPESTNIDTEKTPKKSRVRFSNIMEIRQLPSSHA 141 - 210 LEAKLSRMSYPVKEQESILKTVGKLTATQVAKISFFFCFVWFLANLSYQEALSDTQVAIVNILSSTSGLF 211 - 280 TLILAAVFPSNSGDRFTLSKLLAVILSIGGVVLVNLAGSEKPAGRDTVGSIWSLAGAMLYAVYIVMIKRK 281 - 350 VDREDKLDIPMFFGFVGLFNLLLLWPGFFLLHYTGFEDFEFPNKVVLMCIIINGLIGTVLSEFLWLWGCF 351 - 420 LTSSLIGTLALSLTIPLSIIADMCMQKVQFSWLFFAGAIPVFFSFFIVTLLCHYNNWDPVMVGIRRIFAF 421 - 490 ICRKHRIQRVPEDSEQCESLISMHSVSQEDGAS 491 - 523 //
| PMID | Year | Title | |
|---|---|---|---|
| 23186163 | 2013 | Toward a comprehensive characterization of a human cancer cell phosphoproteome. | |
| 16477629 | 2006 | Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. | |
| 15815621 | 2005 | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | |
| 15489334 | 2004 | The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). | |
| 14702039 | 2004 | Complete sequencing and characterization of 21,243 full-length human cDNAs. | |
| 12975309 | 2003 | The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. | |
| 12477932 | 2002 | Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |
